Physician profile
Mark Thiele
NPI 1467593715
$1,280.96
in general payments reported to CMS, 2019-2025
20 companies · $199 in 2025
The $199 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $882 · 2020: $181 · 2023: $18.91 · 2025: $199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $179 · Travel and Lodging: $39.13.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $178.82 |
| Travel and Lodging | $39.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $202.89 | 2019-2020 | |
| Novo Nordisk INC | $140.54 | 2019-2020 | |
| Moximed, INC | $111.37 | 2025 | Misha Knee System, Small, Left |
| Janssen Pharmaceuticals, INC | $89.09 | 2019-2020 | |
| Amgen INC. | $87.83 | 2019-2020 | |
| Stryker Corporation | $87.67 | 2025 | Blueprint Patient Specific Instrumentation |
| Lilly USA, LLC | $80.65 | 2019-2020 | |
| Amarin Pharma, INC. | $65.05 | 2019-2020 | |
| Avanir Pharmaceuticals, INC. | $57.55 | 2019 | |
| Pfizer INC. | $57.24 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $51.91 | 2019-2020 | |
| Glaxosmithkline, LLC. | $48.60 | 2019 | |
| Sanofi-Aventis U.S. LLC | $41.90 | 2019 | |
| Merck Sharp & Dohme LLC | $38.88 | 2019 | |
| Astellas Pharma US INC | $30.24 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $22.20 | 2020 | |
| Novartis Pharmaceuticals Corporation | $21.70 | 2019 | |
| Exact Sciences Corporation | $18.91 | 2023 | Cologuard Collection Kit |
| Kowa Pharmaceuticals America, INC. | $14.55 | 2019 | |
| Allergan, INC. | $12.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Thiele listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.